Implementation of adherence support for patients with hypertension despite antihypertensive therapy in general practice: A cluster randomized trial

American Journal of Hypertension

Volumn 23, Issue 9, 2010, Pages 1038-1045

  Van De Steeg Van Gompel, Caroline H P A ^a   Wensing, Michel ^a   De Smet, Peter A G M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

blood pressure; community pharmacy services; health plan implementation; hypertension; medication adherence; primary health care

Indexed keywords

ANGIOTENSIN ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT; RENIN INHIBITOR;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GENERAL PRACTICE; HEALTH BEHAVIOR; HEALTH PROGRAM; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT MONITORING; PHARMACY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DIURETICS; FEMALE; HUMANS; HYPERTENSION; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NETHERLANDS; PHARMACIES; PHARMACISTS; TREATMENT OUTCOME;

EID: 77955980970     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2010.63     Document Type: Article

References (33)

1. Grol R. Implementation of changes in practice. In Harrison H, Jackson C (eds), Improving Patient Care. The Implementation of Change in Clinical Practice. Elsevier Butterworth Heinemann: Edinburgh, London, New York, Oxford, Philadelphia, St Louis, Sydney, Toronto, 2005, pp. 6-14.
2. Jamtvedt G, Young JM, Kristoffersen DT, O'Brien MA, Oxman AD. Audit and feedback: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2006:CD000259.
3. Forsetlund L, Bjørndal A, Rashidian A, Jamtvedt G, O'Brien MA, Wolf F, Davis D, Odgaard-Jensen J, Oxman AD. Continuing education meetings and workshops: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2009:CD003030.
4. Shojania KG, Jennings A, Mayhew A, Ramsay CR, Eccles M P, Grimshaw J. The effects of on-screen, point of care computer reminders on processes and outcomes of care. Cochrane Database Syst Rev 2009:CD001096.
5. Farmer A P, Légaré F, Turcot L, Grimshaw J, Harvey E, McGowan JL, Wolf F. Printed educational materials: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2008:CD004398.
6. O'Brien MA, Rogers S, Jamtvedt G, Oxman AD, Odgaard-Jensen J, Kristoffersen DT, Forsetlund L, Bainbridge D, Freemantle N, Davis DA, Haynes RB, Harvey EL. Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2007:CD000409.
7. Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients' care. Lancet 2003; 362:1225-1230.
8. Pereira M, Lunet N, Azevedo A, Barros H. Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J Hypertens 2009; 27:963-975.
9. Sluijs E, van Dulmen S, van Dijk L, de Ridder D, Heerdink R, Bensing J. Patient Adherence to Medical Treatment: A Meta Review. Nivel: Utrecht, 2006.
10. Burnier M, Schneider M P, Chioléro A, Stubi CL, Brunner HR. Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions. J Hypertens 2001; 19:335-341.
11. Santschi V, Rodondi N, Bugnon O, Burnier M. Impact of electronic monitoring of drug adherence on blood pressure control in primary care: a cluster 12-month randomised controlled study. Eur J Intern Med 2008; 19:427-434.
12. Wetzels GE, Nelemans PJ, Schouten JS, Dirksen CD, van der Weijden T, Stoffers HE, Janknegt R, de Leeuw PW, Prins MH. Electronic monitoring of adherence as a tool to improve blood pressure control. A randomized controlled trial. Am J Hypertens 2007; 20:119-125.
13. Christensen A, Osterberg LG, Hansen EH. Electronic monitoring of patient adherence to oral antihypertensive medical treatment: a systematic review. J Hypertens 2009; 27:1540-1551.
14. Stichting Farmaceutische Kengetallen. Verwerkingsgraad bereikt hoogtepunt. Accessed 13 March 2008. Available from.
15. Stichting Farmaceutische Kengetallen. Groei marktaandeel ketens stagneert. Accessed 15 May 2008. Available from.
16. Marentette MA, Gerth WC, Billings DK, Zarnke KB. Antihypertensive persistence and drug class. Can J Cardiol 2002; 18:649-656.
17. Elliott WJ. Improving outcomes in hypertensive patients: focus on adherence and persistence with antihypertensive therapy. J Clin Hypertens (Greenwich) 2009; 11:376-382.
18. Tully, M P, Seston, EM, Cantrill, JA. Motivators and barriers to the implementation of pharmacist-run prescription monitoring and review services in two settings. Int J Pharm Pract 2000; 8:188-197.
19. Dunlop JA, Shaw J P. Community pharmacists' perspectives on pharmaceutical care implementation in New Zealand. Pharm World Sci 2002; 24:224-230.
20. Huyghebaert T, Farris KB, Volume CI. Implementing Pharmaceutical Care: Insights from Alberta Community Pharmacists. CPJ 1999; 132:41-45.
21. Hughes CM, McCann S. Perceived interprofessional barriers between community pharmacists and general practitioners: a qualitative assessment. Br J Gen Pract 2003; 53:600-606.
22. Roberts AS, Benrimoj SI, Chen T, Williams K, Aslani P. An Investigation into Business and Professional Facilitators for Change for the Pharmacy Profession in Light of the Third Guild/Government Agreement (2001-2070). 2003 (cited 2003 May). Available from.
23. van de Steeg-van Gompel C, Wensing M, De Smet PAGM. Implementation of a discontinuation letter to reduce long-term benzodiazepine use\A cluster randomized trial. Drug Alcohol Depend 2009; 99:105-114.
24. Muijrers PE, Knottnerus JA, Sijbrandij J, Janknegt R, Grol R P. Pharmacists in primary care. Determinants of the care-providing function of Dutch community pharmacists in primary care. Pharm World Sci 2004; 26:256-262.
25. WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index 2009. 2009 January (cited 2009 August). Available from.
26. Heisler M, Hogan MM, Hofer T P, Schmittdiel JA, Pladevall M, Kerr EA. When more is not better: treatment intensification among hypertensive patients with poor medication adherence. Circulation 2008; 117:2884-2892.
27. Holland N, Segraves D, Nnadi VO, Belletti DA, Wogen J, Arcona S. Identifying barriers to hypertension care: implications for quality improvement initiatives. Dis Manag 2008; 11:71-77.
28. Rose AJ, Shimada SL, Rothendler JA, Reisman JI, Glassman PA, Berlowitz DR, Kressin NR. The accuracy of clinician perceptions of "usual" blood pressure control. J Gen Intern Med 2008; 23:180-183.
29. Carter BL, Rogers M, Daly J, Zheng S, James PA. The potency of team-based care interventions for hypertension: a meta-analysis. Arch Intern Med 2009; 169:1748-1755.
30. Bosch M, Faber MJ, Cruijsberg J, Voerman GE, Leatherman S, Grol R P, Hulscher M, Wensing M. Review article: Effectiveness of patient care teams and the role of clinical expertise and coordination: a literature review. Med Care Res Rev 2009; 66:5S-35S.
31. Briesacher BA, Andrade SE, Fouayzi H, Chan KA. Medication adherence and use of generic drug therapies. Am J Manag Care 2009; 15:450-456.
32. Siegel D, Lopez J, Meier J. Antihypertensive medication adherence in the Department of Veterans Affairs. Am J Med 2007; 120:26-32.
33. Bramley TJ, Gerbino P P, Nightengale BS, Frech-Tamas F. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm 2006; 12:239-245.